stockrow
Monday 2 November 2026
Export WLKP’s income statement to Excel — free account
Westlake Chemical Partners LP
WLKP Basic Materials Chemicals
Westlake Chemical Partners LP’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 2.71% from fiscal 2024.
- Revenue
- −0.01%
- EPS
- −2.44%
- Free cash flow
- +866.7%
- Total debt
- 0.00%
Quarter to June 2026, against a year earlier
21.97
0.71
+3.34%
Follow WLKP
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
14.99 | 13.77 | 13.47 | 13.66 |
P/S ratio |
0.65 | 0.57 | 0.63 | 0.64 | |
P/FCF ratio |
3.54 | 3.32 | 2.82 | 1.92 | |
P/Operating CF |
7.03 | 5.56 | 7.07 | 6.04 | |
P/B ratio |
0.91 | 0.83 | 0.98 | 1.02 | |
Price to Tangible BV |
0.92 | 0.84 | 0.99 | 1.03 | |
EV/Sales |
1.30 | 1.20 | 1.22 | 1.22 | |
EV/EBITDA |
3.34 | 3.13 | 3.05 | 3.06 | |
EV/Operating CF |
5.05 | 5.00 | 4.38 | 3.25 | |
EV/FCF |
7.07 | 6.95 | 5.47 | 3.70 | |
Quick Ratio |
2.31 | 2.74 | 3.57 | 3.36 | |
Current Ratio |
2.37 | 2.80 | 3.65 | 3.44 | |
Net Debt/EBITDA |
2.87 | 2.86 | 2.94 | 2.86 | |
Debt/Assets |
31.43% | 31.81% | 32.34% | 32.83% | |
Debt/Equity |
0.49 | 0.50 | 0.50 | 0.52 | |
Asset Turnover |
0.88 | 0.92 | 0.95 | 0.98 | |
Operating CF/Net income |
7.18 | 8.28 | 7.78 | 9.12 | |
Capex/Depreciation |
(0.88) | (0.26) | (0.16) | (0.36) | |
Interest Coverage |
15.47 | 16.30 | 17.02 | 17.06 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.41% | 2.18% | 2.35% | 2.52% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.44) | (0.46) | (0.38) | (0.37) | |
Graham Number |
26.96 | 26.59 | 28.80 | 28.30 | |
Earnings Yield |
6.67% | 7.26% | 7.42% | 7.32% | |
Free Cash Flow Yield |
28.27% | 30.12% | 35.51% | 52.15% | |
Revenue per Share |
8.76 | 9.17 | 8.67 | 8.43 | |
Operating CF per Share |
2.99 | 3.42 | 3.13 | 3.68 | |
Capex per Share |
(0.84) | (0.25) | (0.16) | (0.35) | |
Free Cash Flow per Share |
2.14 | 3.17 | 2.97 | 3.33 | |
Cash per Share |
1.08 | 1.26 | 1.26 | 1.40 | |
Shareholders Equity per Share |
23.08 | 22.77 | 22.48 | 21.83 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
23.08 | 22.77 | 22.48 | 21.83 | |
Free Cash Flow |
75.59 | 111.55 | 104.64 | 117.37 | |
Working Capital |
75.73 | 92.21 | 108.11 | 111.77 | |
Capital Expenditures |
(29.65) | (8.83) | (5.56) | (12.48) | |
Net Current Asset Value |
(327.44) | (310.67) | (294.41) | (290.40) | |
EV/EBIT |
4.59 | 4.39 | 4.20 | 4.25 | |
Capex to Sales |
0.10 | 0.03 | 0.02 | 0.04 | |
Price to Operating Income |
2.30 | 2.10 | 2.17 | 2.21 | |
| Other line items | |||||
Average Receivables |
133.07 | 137.09 | 136.95 | 110.65 | |
Average Payables |
27.51 | 33.78 | 60.22 | 31.64 | |
Average Inventory |
3.41 | 3.41 | 2.91 | 3.41 | |
Average Assets |
1,283.15 | 1,272.24 | 1,303.53 | 1,262.27 | |
Average Common Equity |
825.56 | 815.83 | 797.75 | 800.29 |
Columns are period end dates